Mental Retardation or Intellectual Disability is a state of limited ability to function in daily life due to having low to below-average thinking and reasoning skills. It is measured by standardized intelligence test.
Mental Retardation state generally occurs prior to age 18. There are various causes of mental retardation like genetic and environmental factors. In approximately 30 to 50% of cases, the etiology is not identified. Few vary common causes that occur before birth are Down syndrome, Fetal Alcohol Syndrome (FAS), and Fragile X Syndrome.
Depending on intellectual functioning mental retardation may be classified into different levels as mild mental retardation, moderate mental retardation, severe mental retardation and profound mental retardation. Currently there is no curative treatment for mental retardation but corrective treatment can be used effectively to reverse the condition partly or wholly (In rare cases).
Mental retardation treatment varies with the severity of condition. Mental Retardation treatment varies from educating the person and parents to psychotherapy, group therapy.
Etiology based mental retardation treatments are being developed i.e. specific treatment for patient with specific etiology. Prevalence of mental retardation is higher among boys compared to girls.
Mental retardation treatment market is expected grow attributing to prevalence of the condition i.e. mental retardation in United States is 1% to 3% amongst children. Mental retardation treatment market is expected to grow with increased understanding of cellular mechanisms and genetic, novel treatments are being developed for number of specific conditions.
Growing awareness and increasing social inclusion driving patients for the mental retardation treatment. Various initiatives and funding by governments of different countries is another factor which can contribute to mental retardation treatment market growth.
Various private bodies in collaboration with government or independently offering residential facility for mentally retarded people which can drive mental retardation treatment market.
On the other hand mental retardation of unknown etiology remains a challenge for mental retardation treatment market growth. A critical question for these and other treatment options is when to intervene.
Timing of therapeutic intervention decides success of treatment in some cases. Many caregivers look for in house care which makes difficult to treat patients.
New developing etiology based mental retardation treatments are major change in mental retardation treatment market. Raising Awareness and Combating Stigma about mental retardation is the major change is global mental retardation treatment market mainly in developing countries.
Global market of mental retardation shows significant growth due to increased awareness about treatment. New therapies like stem cell therapy are expected to raise potential of mental retardation treatment market.
By drug type psychotropic medications are mostly preferred for mental retardation treatment market. By distribution channel retail pharmacies are prominent segment owing the high preference.
Mental retardation treatment market is mainly focusing on developing therapies which can cure mental retardation caused by genetic factors.
On the basis of regional presence mental retardation treatment market is classified into eight key regions - North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding China & Japan, China, Japan, and the Middle East & Africa.
Mental Retardation treatment market across North America is expected to remain most lucrative and steady attributed to steady prevalence. Mental retardation is significantly more common in low-income countries (Middle East, Africa) – 16.41 in every 1,000 people.
MEA are least adapting market owing to less awareness. There are about 7 million people living with mental retardation in Eastern Europe and Western Europe.
Europe is regarded as the best suited place for people with mental retardation which makes easier access for treatment driving growth of Mental Retardation treatment Market.
Mental retardation treatment market for Asia Pacific region along with China and Japan is expected to grow attributing to larger population and increasing awareness.
Key players involved in the global mental retardation treatment markets are Pfizer, Inc., Forest Laboratories, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb Company, Wyeth, Teva Pharmaceutical Industries Ltd., and Biogen, Inc.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data.
It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The global Mental retardation treatment market is classified on the basis of drug type, Distribution channels and region
Based on drug type mental retardation treatment market is segmented into following:
Based on distribution channels mental retardation treatment market is segmented into following:
Explore Similar Insights
Mental Retardation Treatment Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
